Bain Capital-backed Emcure Pharma to float IPO on July 3

Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer of Sale. Proceeds will be used for debt payment and corporate purposes.